CAS: 1799328-86-1
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | ASTX660 REF: 54-BUP04890CAS: 1799328-86-1 | 98% | 646.00 €~1,230.00 € | Thu 24 Apr 25 |
 | ASTX660 REF: TM-TQ0029CAS: 1799328-86-1 | 97.81% - 98.33% | 84.00 €~908.00 € | Wed 30 Apr 25 |
 | ASTX 660 REF: 3D-BA166845CAS: 1799328-86-1 | Min. 95% | 2,791.00 €~5,709.00 € | Wed 04 Jun 25 |
Ref: 54-BUP04890
| 25mg | 646.00 € | ||
| 50mg | 938.00 € | ||
| 100mg | 1,230.00 € |
Estimated delivery in United States, on Thursday 24 Apr 2025
ASTX660
CAS:1799328-86-1
Tolinapant (ASTX660) is an orally bioavailable cIAP1/2 and XIAP antagonist.Cost-effective and quality-assured.
Formula:
C30H42FN5O3
Purity:
97.81% - 98.33%
Color and Shape:
Solid
Molecular weight:
539.68
Ref: TM-TQ0029
| 1mg | 84.00 € | ||
| 5mg | 144.00 € | ||
| 10mg | 216.00 € | ||
| 25mg | 432.00 € | ||
| 50mg | 638.00 € | ||
| 100mg | 908.00 € | ||
| 1mL*10mM (DMSO) | 172.00 € |
Estimated delivery in United States, on Wednesday 30 Apr 2025
ASTX 660
CAS:1799328-86-1
Antagonist of the inhibitor-of-apoptosis-proteins cIAP1/2 and XIAP
Formula:
C30H42FN5O3
Purity:
Min. 95%
Molecular weight:
539.68 g/mol
Ref: 3D-BA166845
| 1g | 5,709.00 € | ||
| 250mg | 2,791.00 € | ||
| 500mg | 4,060.00 € |
Estimated delivery in United States, on Wednesday 4 Jun 2025
